Jacob Smith

25 May 2026

Sun Pharmaceuticals agreed to acquire US-based Organon & Co in a mass… – Jacob Smith

Sun Pharmaceuticals agreed to acquire US-based Organon & Co in a massive $11.75 billion deal, marking one of the biggest overseas acquisitions by an Indian company in nearly two decades. The agreement reflects the growing global ambitions of Indian corporations, following major international deals by Tata Motors, Coforge, and the Bajaj Group. Analysts say outbound acquisitions by Indian firms rose sharply in 2025 amid expanding global investment strategies. #India #Business #SunPharma #Economy #